187 related articles for article (PubMed ID: 15289293)
1. Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels.
De Petrocellis L; Chu CJ; Moriello AS; Kellner JC; Walker JM; Di Marzo V
Br J Pharmacol; 2004 Sep; 143(2):251-6. PubMed ID: 15289293
[TBL] [Abstract][Full Text] [Related]
2. N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia.
Chu CJ; Huang SM; De Petrocellis L; Bisogno T; Ewing SA; Miller JD; Zipkin RE; Daddario N; Appendino G; Di Marzo V; Walker JM
J Biol Chem; 2003 Apr; 278(16):13633-9. PubMed ID: 12569099
[TBL] [Abstract][Full Text] [Related]
3. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 Apr; 141(7):1118-30. PubMed ID: 15006899
[TBL] [Abstract][Full Text] [Related]
4. Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors.
Millns PJ; Chimenti M; Ali N; Ryland E; de Lago E; Fernandez-Ruiz J; Chapman V; Kendall DA
Eur J Neurosci; 2006 Dec; 24(12):3489-95. PubMed ID: 17229097
[TBL] [Abstract][Full Text] [Related]
5. Endovanilloids are potential activators of the trigeminovascular nocisensor complex.
Dux M; Deák É; Tassi N; Sántha P; Jancsó G
J Headache Pain; 2016; 17():53. PubMed ID: 27189587
[TBL] [Abstract][Full Text] [Related]
6. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
[TBL] [Abstract][Full Text] [Related]
7. Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels.
Van Der Stelt M; Di Marzo V
Eur J Biochem; 2004 May; 271(10):1827-34. PubMed ID: 15128293
[TBL] [Abstract][Full Text] [Related]
8. TRPV1 and CB(1) receptor-mediated effects of the endovanilloid/endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat.
Sagar DR; Smith PA; Millns PJ; Smart D; Kendall DA; Chapman V
Eur J Neurosci; 2004 Jul; 20(1):175-84. PubMed ID: 15245490
[TBL] [Abstract][Full Text] [Related]
9. The antinociceptive potency of N-arachidonoyl-dopamine (NADA) and its interaction with endomorphin-1 at the spinal level.
Farkas I; Tuboly G; Benedek G; Horvath G
Pharmacol Biochem Behav; 2011 Oct; 99(4):731-7. PubMed ID: 21624393
[TBL] [Abstract][Full Text] [Related]
10.
Lawton SK; Xu F; Tran A; Wong E; Prakash A; Schumacher M; Hellman J; Wilhelmsen K
J Immunol; 2017 Aug; 199(4):1465-1475. PubMed ID: 28701511
[No Abstract] [Full Text] [Related]
11. Up-regulation of TRPV1 in mononuclear cells of end-stage kidney disease patients increases susceptibility to N-arachidonoyl-dopamine (NADA)-induced cell death.
Saunders CI; Fassett RG; Geraghty DP
Biochim Biophys Acta; 2009 Oct; 1792(10):1019-26. PubMed ID: 19619644
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of capsaicin-, anandamide-, and N-arachidonoyl-dopamine-evoked cell death in a homogeneous transient receptor potential vanilloid subtype 1 receptor population.
Davies JW; Hainsworth AH; Guerin CJ; Lambert DG
Br J Anaesth; 2010 May; 104(5):596-602. PubMed ID: 20354008
[TBL] [Abstract][Full Text] [Related]
13. Effects of anandamide and noxious heat on intracellular calcium concentration in nociceptive drg neurons of rats.
Fischbach T; Greffrath W; Nawrath H; Treede RD
J Neurophysiol; 2007 Aug; 98(2):929-38. PubMed ID: 17581853
[TBL] [Abstract][Full Text] [Related]
14. Anandamide and NADA bi-directionally modulate presynaptic Ca2+ levels and transmitter release in the hippocampus.
Köfalvi A; Pereira MF; Rebola N; Rodrigues RJ; Oliveira CR; Cunha RA
Br J Pharmacol; 2007 Jun; 151(4):551-63. PubMed ID: 17435795
[TBL] [Abstract][Full Text] [Related]
15. Increased depressor response to N-arachidonoyl-dopamine during high salt intake: role of the TRPV1 receptor.
Wang Y; Wang DH
J Hypertens; 2007 Dec; 25(12):2426-33. PubMed ID: 17984664
[TBL] [Abstract][Full Text] [Related]
16. Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists.
Brown BS; Keddy R; Zheng GZ; Schmidt RG; Koenig JR; McDonald HA; Bianchi BR; Honore P; Jarvis MF; Surowy CS; Polakowski JS; Marsh KC; Faltynek CR; Lee CH
Bioorg Med Chem; 2008 Sep; 16(18):8516-25. PubMed ID: 18722778
[TBL] [Abstract][Full Text] [Related]
17. Biochemistry and pharmacology of endovanilloids.
Starowicz K; Nigam S; Di Marzo V
Pharmacol Ther; 2007 Apr; 114(1):13-33. PubMed ID: 17349697
[TBL] [Abstract][Full Text] [Related]
18. N-acyldopamines control striatal input terminals via novel ligand-gated cation channels.
Ferreira SG; Lomaglio T; Avelino A; Cruz F; Oliveira CR; Cunha RA; Köfalvi A
Neuropharmacology; 2009 Mar; 56(3):676-83. PubMed ID: 19101577
[TBL] [Abstract][Full Text] [Related]
19. Excitation of cutaneous C nociceptors by intraplantar administration of anandamide.
Potenzieri C; Brink TS; Simone DA
Brain Res; 2009 May; 1268():38-47. PubMed ID: 19285051
[TBL] [Abstract][Full Text] [Related]
20. Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids.
De Petrocellis L; Starowicz K; Moriello AS; Vivese M; Orlando P; Di Marzo V
Exp Cell Res; 2007 May; 313(9):1911-20. PubMed ID: 17428469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
